BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30252863)

  • 1. Hepatocellular carcinoma among US and non-US-born patients with chronic hepatitis B: Risk factors and age at diagnosis.
    Kennedy K; Graham SM; Arora N; Shuhart MC; Kim HN
    PLoS One; 2018; 13(9):e0204031. PubMed ID: 30252863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for early-onset and late-onset hepatocellular carcinoma in Asian immigrants with hepatitis B in the United States.
    Wan DW; Tzimas D; Smith JA; Kim S; Araujo J; David R; Lobach I; Sarpel U
    Am J Gastroenterol; 2011 Nov; 106(11):1994-2000. PubMed ID: 21912436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
    Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
    Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma: Clinical-pathological features and HIV infection in Mozambican patients.
    Cunha L; Carrilho C; Bhatt N; Loforte M; Maueia C; Fernandes F; Guisseve A; Mbofana F; Maibaze F; Mondlane L; Ismail M; Dimande L; Machatine S; Lunet N; Liu YT; Gudo ES; Pineau P
    Cancer Treat Res Commun; 2019; 19():100129. PubMed ID: 30903933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk profile of hepatocellular carcinoma reveals dichotomy among US veterans.
    Karagozian R; Baker E; Houranieh A; Leavitt D; Baffy G
    J Gastrointest Cancer; 2013 Sep; 44(3):318-24. PubMed ID: 23609167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: A retrospective cohort study.
    Marcon PDS; Tovo CV; Kliemann DA; Fisch P; de Mattos AA
    World J Gastroenterol; 2018 Feb; 24(5):613-622. PubMed ID: 29434450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in Hepatocellular Carcinoma Incidence and Risk Among Persons With HIV in the US and Canada, 1996-2015.
    Sun J; Althoff KN; Jing Y; Horberg MA; Buchacz K; Gill MJ; Justice AC; Rabkin CS; Goedert JJ; Sigel K; Cachay E; Park L; Lim JK; Kim HN; Lo Re V; Moore R; Sterling T; Peters MG; Achenbach CJ; Silverberg M; Thorne JE; Mayor AM; Crane HM; Kitahata MM; Klein M; Kirk GD;
    JAMA Netw Open; 2021 Feb; 4(2):e2037512. PubMed ID: 33595662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial differences in the progression to cirrhosis and hepatocellular carcinoma in HCV-infected veterans.
    El-Serag HB; Kramer J; Duan Z; Kanwal F
    Am J Gastroenterol; 2014 Sep; 109(9):1427-35. PubMed ID: 25070058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etiology of hepatocellular carcinoma in West Africa, a case-control study.
    Jaquet A; Tchounga B; Tanon A; Bagny A; Ekouevi DK; Traore HA; Sasco AJ; Maiga M; Dabis F
    Int J Cancer; 2018 Aug; 143(4):869-877. PubMed ID: 29569722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study.
    Oh JK; Shin HR; Lim MK; Cho H; Kim DI; Jee Y; Yun H; Yoo KY
    BMC Cancer; 2012 Oct; 12():452. PubMed ID: 23039099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans.
    El-Serag HB; Richardson PA; Everhart JE
    Am J Gastroenterol; 2001 Aug; 96(8):2462-7. PubMed ID: 11513191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma in cirrhosis: incidence and risk factors.
    Fattovich G; Stroffolini T; Zagni I; Donato F
    Gastroenterology; 2004 Nov; 127(5 Suppl 1):S35-50. PubMed ID: 15508101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic hepatitis B and liver cancer risks among Asian immigrants in New York City: Results from a large, community-based screening, evaluation, and treatment program.
    Pollack HJ; Kwon SC; Wang SH; Wyatt LC; Trinh-Shevrin C;
    Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2229-39. PubMed ID: 25368398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients.
    Kruse RL; Kramer JR; Tyson GL; Duan Z; Chen L; El-Serag HB; Kanwal F
    Hepatology; 2014 Dec; 60(6):1871-8. PubMed ID: 25065513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for hepatocellular carcinoma in a cohort infected with hepatitis B or C.
    Walter SR; Thein HH; Gidding HF; Amin J; Law MG; George J; Dore GJ
    J Gastroenterol Hepatol; 2011 Dec; 26(12):1757-64. PubMed ID: 21615789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral therapy for chronic hepatitis B virus infection and development of hepatocellular carcinoma in a US population.
    Gordon SC; Lamerato LE; Rupp LB; Li J; Holmberg SD; Moorman AC; Spradling PR; Teshale EH; Vijayadeva V; Boscarino JA; Henkle EM; Oja-Tebbe N; Lu M;
    Clin Gastroenterol Hepatol; 2014 May; 12(5):885-93. PubMed ID: 24107395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infection.
    Ioannou GN; Bryson CL; Weiss NS; Miller R; Scott JD; Boyko EJ
    Hepatology; 2013 Jan; 57(1):249-57. PubMed ID: 22532055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A comparative cross-sectional study of the development of hepatocellular carcinoma in patients with liver cirrhosis caused by hepatitis B virus, alcohol, or combination of hepatitis b virus and alcohol].
    Chung NS; Kwon OS; Park CH; Kim YN; Cho GH; Lee JJ; Kim GH; Kim HO; Ko KI; Yu SK; Kwon KA; Kim YS; Choi DJ; Kim JH
    Korean J Gastroenterol; 2007 Jun; 49(6):369-75. PubMed ID: 17641555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States.
    Welzel TM; Graubard BI; Quraishi S; Zeuzem S; Davila JA; El-Serag HB; McGlynn KA
    Am J Gastroenterol; 2013 Aug; 108(8):1314-21. PubMed ID: 23752878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.